Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation

Exclusion Criteria

• •Patients who have received in vitro radiation therapy, systemic chemotherapy within 4 weeks based on sign date of Informed consent form.
• •Patients who undergo ABO incompatible Liver Transplantation.
• •Patients who had previously administered cell therapy.
• •Patients who are confirmed with Acquired Immune Deficiency Syndrome (AIDS).
• •Patients who are currently receiving dialysis.
• •Patients who participated in another clinical trial and received treatment in 4 weeks or have a plan for administration of another clinical trial treatment since Informed consent form sign date.
• •Patients who have uncontrollable or serious disease.
• •Patients who are unable to use appropriate methods of contraception during the study period.
• •Patient whose tumor has not been removed or liver metastasis is confirmed.